Fareston
Term · Oncology and biomedicine · MLC-T-ONC-003134
A drug used to treat postmenopausal women with breast cancer that has spread to other parts of the body. It is used in patients whose cancer is estrogen receptor positive (ER+) or when it is not known if the cancer is ER+ or estrogen receptor negative (ER-). Fareston blocks the effects of the hormone estrogen in breast tissue, which may help keep breast cancer cells from growing. It is a type of selective estrogen receptor modulator (SERM). Also called toremifene citrate.
| Identifier | MLC-T-ONC-003134 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | toremifene citrate |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-003134",
"term": "Fareston",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat postmenopausal women with breast cancer that has spread to other parts of the body. It is used in patients whose cancer is estrogen receptor positive (ER+) or when it is not known if the cancer is ER+ or estrogen receptor negative (ER-). Fareston blocks the effects of the hormone estrogen in breast tissue, which may help keep breast cancer cells from growing. It is a type of selective estrogen receptor modulator (SERM). Also called toremifene citrate.",
"synonyms": [
"toremifene citrate"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/fareston/"
}
Record 7,154 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.